No abstract available
MeSH terms
-
3',5'-Cyclic-GMP Phosphodiesterases / antagonists & inhibitors*
-
Atherosclerosis / complications
-
Carbolines / adverse effects
-
Carbolines / therapeutic use
-
Erectile Dysfunction / drug therapy
-
Humans
-
Imidazoles / adverse effects
-
Imidazoles / therapeutic use
-
Male
-
Optic Neuropathy, Ischemic / chemically induced*
-
Phosphodiesterase Inhibitors / adverse effects*
-
Phosphodiesterase Inhibitors / therapeutic use
-
Piperazines / adverse effects
-
Piperazines / therapeutic use
-
Purines
-
Risk Factors
-
Sildenafil Citrate
-
Sulfones / adverse effects
-
Sulfones / therapeutic use
-
Tadalafil
-
Triazines / adverse effects
-
Triazines / therapeutic use
-
Vardenafil Dihydrochloride
-
Vision Disorders / chemically induced*
Substances
-
Carbolines
-
Imidazoles
-
Phosphodiesterase Inhibitors
-
Piperazines
-
Purines
-
Sulfones
-
Triazines
-
Vardenafil Dihydrochloride
-
Tadalafil
-
Sildenafil Citrate
-
3',5'-Cyclic-GMP Phosphodiesterases